trial

Motivational Interviewing to Improve Work Outcomes in Schizophrenia

NCTId NCT00261716
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Completed
Enrollment 38 (actual)
Sponsored by VA Office of Research and Development
Primary completion 2008-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Completed
Enrollment
38 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2005-01
Primary completion
2008-09
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
IPSIEVOMI

Sponsors

VA Office of Research and DevelopmentLead Sponsor

Investigators

1
Shirley M. Glynn, PhDPrincipal Investigator

Sites

1 total
West Los Angeles, United States

Linked catalysts

1
Motivational Interviewing to Improve Work Outcomes in Schizophrenia — primary completion2008-09

Facts & assertions

4 sourced
Enrollment
38
Phase
PHASE3
Primary Completion Date
2008-09
Status
COMPLETED
relationships
The graph out of here
drug
IPS
drug
IE
drug
VOMI
drug
lead_sponsor
VA Office of Research and Development
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication
investigator
Shirley M. Glynn, PhD
person